• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初始心率评分可预测起搏器患者新发房性心动过速。

Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients.

机构信息

Cardiac Electrophysiology and Pacing Section, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue Desk J2-2, Cleveland, OH 44195, USA.

Department of Heart Rhythm Management, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad242.

DOI:10.1093/europace/euad242
PMID:37552791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10440628/
Abstract

AIMS

Heart rate score (HRSc), the per cent of atrial paced and sensed event in the largest 10 b.p.m. rate histogram bin of a pacemaker, predicts survival in patients with cardiac devices. No correlation between HRSc and development of atrial fibrillation (AF) has been reported. In this study, we evaluated the relationship between pacemaker post-implantation HRSc and the incidence of newly developed atrial tachyarrhythmias (ATAs).

METHODS AND RESULTS

Patients with dual-chamber pacemakers, implanted 2013-17, with the LATITUDE remote monitoring data with ≥600 000 beats of histogram data collected at baseline were included (N = 34 543). Heart rate score was determined from the initial 3-month post-implantation histogram data. Patients were excluded if they had ATAs, defined as atrial high-rate episodes >5 min or >1% of right atrial beats >170 b.p.m. during the initial 3 months post-implantation. New ATAs, after the baseline period, were defined by each of the following: >1, >10, or >25% of atrial beats >170 b.p.m. or atrial tachycardia response (ATR) events >24 h. Patients were followed a median of 2.8 (1.0-4.0) years. The incidence of ATAs increased in proportion to HRSc (log-rank P-value <0.001), and the initial HRSc ≥70% was associated with increased ATAs by all definitions. Patients with initial HRSc ≥70% were older, had a higher percentage of right atrium pacing (%RA pacing), had a lower percentage of right ventricular pacing (%RV pacing), and were more likely programmed with rate-response vs. subjects with HRSc <70%. Initial HRSc (hazard ratio: 1.07, 95% confidence interval: 1.05-1.09; P < 0.0001) independently predicted ATAs after adjusting for age, gender, %RV pacing, and rate-response programming. The %RA pacing and initial HRSc were correlated.

CONCLUSION

Heart rate score independently predicts any subsequent duration of ATAs in pacemaker patients.

摘要

目的

心率得分(HRSc)是起搏器中最大 10 bpm 速率直方图 bin 中感知到的心房起搏和感知事件的百分比,可预测心脏设备患者的生存率。尚未报道 HRSc 与心房颤动(AF)发展之间存在相关性。在这项研究中,我们评估了起搏器植入后 HRSc 与新发性房性心动过速(ATAs)发生率之间的关系。

方法和结果

纳入 2013-17 年植入双腔起搏器、具有 LATITUDE 远程监测数据且在基线时收集了≥600000 个 beats 直方图数据的患者(N=34543)。HRSc 是从初始植入后 3 个月的直方图数据中确定的。如果患者在初始植入后 3 个月内出现 ATAs(定义为心房高心率发作>5 分钟或>右心房 beats 的 1%>170 bpm),则排除患者。在基线期后,将新的 ATAs 定义为每个以下定义的>1、>10 或>25%的心房 beats >170 bpm 或心房心动过速反应(ATR)事件>24 h。患者中位随访时间为 2.8(1.0-4.0)年。ATAs 的发生率与 HRSc 呈比例增加(对数秩 P 值<0.001),初始 HRSc ≥70%与所有定义的 ATAs 增加相关。初始 HRSc ≥70%的患者年龄较大,右心房起搏百分比(%RA 起搏)较高,右心室起搏百分比(%RV 起搏)较低,与 HRSc<70%的患者相比,更有可能程控为频率反应。初始 HRSc(风险比:1.07,95%置信区间:1.05-1.09;P<0.0001)在调整年龄、性别、%RV 起搏和频率反应程控后,独立预测 ATAs。%RA 起搏和初始 HRSc 呈正相关。

结论

HRSc 独立预测起搏器患者任何随后的 ATAs 持续时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/62d52b07173e/euad242f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/078a52b7029e/euad242_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/f3b7c06d7685/euad242f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/b0421fa5b9a0/euad242f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/057f48f4e460/euad242f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/4958a17ce0ac/euad242f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/926589c6e642/euad242f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/c0a9d3f866d3/euad242f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/62d52b07173e/euad242f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/078a52b7029e/euad242_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/f3b7c06d7685/euad242f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/b0421fa5b9a0/euad242f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/057f48f4e460/euad242f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/4958a17ce0ac/euad242f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/926589c6e642/euad242f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/c0a9d3f866d3/euad242f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197c/10440628/62d52b07173e/euad242f7.jpg

相似文献

1
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients.初始心率评分可预测起搏器患者新发房性心动过速。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad242.
2
High initial heart rate score is an independent predictor of new atrial high-rate episodes in pacemaker patients with sinus node dysfunction.初始心率高评分是窦房结功能障碍的起搏器患者新发心房快速性心律失常事件的独立预测因子。
Heart Rhythm. 2024 Dec;21(12):2543-2551. doi: 10.1016/j.hrthm.2024.06.046. Epub 2024 Jun 25.
3
Lower rate limit for pacing by cardiac resynchronization defibrillators: Should lower rate programming be reconsidered?心脏再同步除颤器起搏下限频率:是否应重新考虑较低的程控频率?
Heart Rhythm. 2021 Dec;18(12):2087-2093. doi: 10.1016/j.hrthm.2021.07.068. Epub 2021 Aug 8.
4
Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.双腔起搏器植入后提高心房起搏基础频率预防心房颤动:来自心房超速起搏研究的见解
Europace. 2007 Nov;9(11):1024-30. doi: 10.1093/europace/eum170. Epub 2007 Oct 3.
5
Addition of minute ventilation to rate-response pacing improves heart rate score more than accelerometer alone.增加分钟通气量到反应性起搏可改善心率评分,优于单独使用加速度计。
Heart Rhythm. 2018 Nov;15(11):1730-1735. doi: 10.1016/j.hrthm.2018.06.021. Epub 2018 Jun 13.
6
Survival After Rate-Responsive Programming in Patients With Cardiac Resynchronization Therapy-Defibrillator Implants Is Associated With a Novel Parameter: The Heart Rate Score.心脏再同步治疗除颤器植入患者的心率反应性编程后生存率与一个新参数相关:心率评分。
Circ Arrhythm Electrophysiol. 2016 Aug;9(8). doi: 10.1161/CIRCEP.115.003806.
7
New-onset atrial high-rate episodes between his bundle pacing and conventional right ventricular septum pacing in patients with atrioventricular conduction disturbance.房室传导阻滞患者希氏束起搏与传统右室间隔部起搏中新发的房性快速心律失常事件。
J Interv Card Electrophysiol. 2024 Apr;67(3):471-477. doi: 10.1007/s10840-023-01605-w. Epub 2023 Jul 3.
8
Heart rate score and outcomes in ICD patients: insights from the prospective randomized INTRINSIC RV trial.ICD 患者的心率评分与结局:前瞻性随机 INTRINSIC RV 试验的结果。
J Interv Card Electrophysiol. 2022 Jun;64(1):87-93. doi: 10.1007/s10840-021-01091-y. Epub 2021 Nov 15.
9
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.新一代心房抗心动过速起搏(反应性 ATP)与心动过缓患者持续性或永久性心房颤动风险降低相关:MINERVA 随机多中心国际试验的结果。
Heart Rhythm. 2015 Aug;12(8):1717-25. doi: 10.1016/j.hrthm.2015.04.015. Epub 2015 Apr 11.
10
Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode.永久性起搏器患者新发心房颤动的发生率及其与起搏模式的关系。
Med Sci Monit. 2014 Feb 18;20:268-73. doi: 10.12659/MSM.890052.

引用本文的文献

1
New-Onset Atrial Fibrillation in Patients with Pacemakers and the Implications of Hepatic Impairment.起搏器植入患者新发心房颤动及肝功能损害的影响
Life (Basel). 2025 Mar 13;15(3):450. doi: 10.3390/life15030450.

本文引用的文献

1
Heart rate score and outcomes in ICD patients: insights from the prospective randomized INTRINSIC RV trial.ICD 患者的心率评分与结局:前瞻性随机 INTRINSIC RV 试验的结果。
J Interv Card Electrophysiol. 2022 Jun;64(1):87-93. doi: 10.1007/s10840-021-01091-y. Epub 2021 Nov 15.
2
Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality.远程监测心脏植入式电子设备的数据可预测全因死亡率。
Europace. 2022 Feb 2;24(2):245-255. doi: 10.1093/europace/euab160.
3
Heart rate score, a measure related to chronotropic incompetence in pacemaker patients.
心率评分,一种与起搏器患者变时性功能不全相关的测量指标。
Heart Rhythm O2. 2021 Feb 20;2(2):124-131. doi: 10.1016/j.hroo.2021.02.002. eCollection 2021 Apr.
4
CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening.CHARGE-AF 在荷兰全国常规初级保健电子健康记录数据库中的应用:5 年心房颤动风险的验证及其对心房颤动筛查中患者选择的意义。
Open Heart. 2021 Jan;8(1). doi: 10.1136/openhrt-2020-001459.
5
Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.通过植入式设备的远程传输,对心房颤动进展过程中的电重构进行个体化监测。
Europace. 2020 May 1;22(5):704-715. doi: 10.1093/europace/euz331.
6
Heart Failure and Atrial Fibrillation, Like Fire and Fury.心力衰竭与心房颤动:如影随形。
JACC Heart Fail. 2019 Jun;7(6):447-456. doi: 10.1016/j.jchf.2019.03.005.
7
Chronotropic Incompetence in Chronic Heart Failure.慢性心力衰竭的变时性功能不全。
Circ Heart Fail. 2018 Aug;11(8):e004969. doi: 10.1161/CIRCHEARTFAILURE.118.004969.
8
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).社区队列中心房颤动的流行病学、危险因素及死亡率的性别差异与相似性:欧洲心血管风险评估生物标志物(BiomarCaRE)联盟的研究结果
Circulation. 2017 Oct 24;136(17):1588-1597. doi: 10.1161/CIRCULATIONAHA.117.028981. Epub 2017 Oct 16.
9
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.探索心房高率发作患者的口服抗凝治疗:心房高率发作患者非维生素K拮抗剂口服抗凝剂(NOAH-AFNET 6)试验的原理与设计
Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.
10
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.阿哌沙班用于降低器械检测到的亚临床房颤患者血栓栓塞事件(ARTESiA)试验的原理与设计
Am Heart J. 2017 Jul;189:137-145. doi: 10.1016/j.ahj.2017.04.008. Epub 2017 Apr 24.